DE60113496D1 - Verwendung von Glycyrrhizin zur Behandlung von Mastitis. - Google Patents

Verwendung von Glycyrrhizin zur Behandlung von Mastitis.

Info

Publication number
DE60113496D1
DE60113496D1 DE60113496T DE60113496T DE60113496D1 DE 60113496 D1 DE60113496 D1 DE 60113496D1 DE 60113496 T DE60113496 T DE 60113496T DE 60113496 T DE60113496 T DE 60113496T DE 60113496 D1 DE60113496 D1 DE 60113496D1
Authority
DE
Germany
Prior art keywords
glycyrrhizin
mastitis
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60113496T
Other languages
English (en)
Other versions
DE60113496T2 (de
Inventor
Katsuo Kumagai
Kenzo Kai
Ken-Ichi Komine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CELL RES INST TOKIO TOKYO T
Kyoritsu Seiyaku Corp
Original Assignee
CELL RES INST TOKIO TOKYO T
Kyoritsu Seiyaku Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CELL RES INST TOKIO TOKYO T, Kyoritsu Seiyaku Corp filed Critical CELL RES INST TOKIO TOKYO T
Publication of DE60113496D1 publication Critical patent/DE60113496D1/de
Application granted granted Critical
Publication of DE60113496T2 publication Critical patent/DE60113496T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DE60113496T 2000-11-24 2001-11-23 Verwendung von Glycyrrhizin zur Behandlung von Mastitis. Expired - Lifetime DE60113496T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2000358055 2000-11-24
JP2000358055 2000-11-24
JP2001046565 2001-02-22
JP2001046565A JP3435405B2 (ja) 2000-11-24 2001-02-22 家畜の乳房炎治療剤及びこれを用いた乳房炎の治療方法

Publications (2)

Publication Number Publication Date
DE60113496D1 true DE60113496D1 (de) 2006-02-02
DE60113496T2 DE60113496T2 (de) 2006-07-06

Family

ID=26604550

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60113496T Expired - Lifetime DE60113496T2 (de) 2000-11-24 2001-11-23 Verwendung von Glycyrrhizin zur Behandlung von Mastitis.

Country Status (6)

Country Link
US (2) US20020115622A1 (de)
EP (1) EP1208844B1 (de)
JP (1) JP3435405B2 (de)
CA (1) CA2363990C (de)
DE (1) DE60113496T2 (de)
ES (1) ES2246282T3 (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7234414B2 (en) * 1999-11-18 2007-06-26 Sensortec Limited Mastitis detection
DE10224387A1 (de) 2002-06-01 2003-12-11 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem aufbereiteten Extrakt aus Radix Glycyrrhizae inflatae
CA2534259C (en) * 2003-08-12 2012-04-24 Nippon Zoki Pharmaceutical Co., Ltd. Glycyrrhizin high-concentration preparation
DE10352367A1 (de) * 2003-11-10 2005-06-09 Beiersdorf Ag Verwendung von Licochalkon A gegen Rosacea
DE10352369A1 (de) * 2003-11-10 2005-06-09 Beiersdorf Ag Verwendung von Licocalchon A oder eines Licocalchon A enthaltenden Extraktes aus Radix Glycyrrhizae inflatae gegen postinflammatorische Hyperpigmentierung
DE10357046A1 (de) * 2003-12-04 2005-06-30 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen enthaltend eine Kombination aus grünem Farbstoff und antiinflammatorischem Wirkstoff
DE102004012135A1 (de) * 2004-03-12 2005-09-29 Beiersdorf Ag Zubereitung gegen gerötete Haut
CN100348094C (zh) * 2005-01-10 2007-11-14 西北农林科技大学 一种奶牛隐性乳房炎的诊断试剂
CN100460866C (zh) * 2005-11-23 2009-02-11 山东奥克斯生物技术有限公司 牛、羊、猪乳房炎快速诊断试剂及其制备方法
US9943614B2 (en) 2008-06-17 2018-04-17 Brigham Young University Cationic steroid antimicrobial diagnostic, detection, screening and imaging methods
BR112014001444A2 (pt) 2011-07-20 2017-07-18 Univ Brigham Young compostos hidrofóbicos de ceragenina e dispositivos que incorporam os mesmos
US9694019B2 (en) 2011-09-13 2017-07-04 Brigham Young University Compositions and methods for treating bone diseases and broken bones
US9603859B2 (en) 2011-09-13 2017-03-28 Brigham Young University Methods and products for increasing the rate of healing of tissue wounds
MX2014007496A (es) 2011-12-21 2015-02-17 Univ Brigham Young Composiciones para el cuidado oral.
US9533063B1 (en) 2012-03-01 2017-01-03 Brigham Young University Aerosols incorporating ceragenin compounds and methods of use thereof
EP2846634A2 (de) 2012-05-02 2015-03-18 Brigham Young University Partikelförmige cerageninmaterialien und verfahren zur herstellung davon
WO2014062960A1 (en) * 2012-10-17 2014-04-24 Brigham Young University Treatment and prevention of mastitis
EP2941253B1 (de) 2013-01-07 2021-08-11 Brigham Young University Antimikrobielle kationische steroide zur behandlung von krebs
US11524015B2 (en) 2013-03-15 2022-12-13 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
US10568893B2 (en) 2013-03-15 2020-02-25 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
CA2907082C (en) 2013-03-15 2021-05-04 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
US9387215B2 (en) 2013-04-22 2016-07-12 Brigham Young University Animal feed including cationic cholesterol additive and related methods
US11690855B2 (en) 2013-10-17 2023-07-04 Brigham Young University Methods for treating lung infections and inflammation
US20150203527A1 (en) 2014-01-23 2015-07-23 Brigham Young University Cationic steroidal antimicrobials
CA2844321C (en) 2014-02-27 2021-03-16 Brigham Young University Cationic steroidal antimicrobial compounds
US10220045B2 (en) 2014-03-13 2019-03-05 Brigham Young University Compositions and methods for forming stabilized compositions with reduced CSA agglomeration
US9867836B2 (en) 2014-03-13 2018-01-16 Brigham Young University Lavage and/or infusion using CSA compounds for increasing fertility in a mammal
US9931350B2 (en) 2014-03-14 2018-04-03 Brigham Young University Anti-infective and osteogenic compositions and methods of use
US9686966B2 (en) 2014-04-30 2017-06-27 Brigham Young University Methods and apparatus for cleaning or disinfecting a water delivery system
US10441595B2 (en) 2014-06-26 2019-10-15 Brigham Young University Methods for treating fungal infections
US10238665B2 (en) 2014-06-26 2019-03-26 Brigham Young University Methods for treating fungal infections
US10227376B2 (en) 2014-08-22 2019-03-12 Brigham Young University Radiolabeled cationic steroid antimicrobials and diagnostic methods
US10155788B2 (en) 2014-10-07 2018-12-18 Brigham Young University Cationic steroidal antimicrobial prodrug compositions and uses thereof
US10370403B2 (en) 2015-04-22 2019-08-06 Brigham Young University Methods for the synthesis of ceragenins
WO2016172553A1 (en) 2015-04-22 2016-10-27 Savage Paul B Methods for the synthesis of ceragenins
US9434759B1 (en) 2015-05-18 2016-09-06 Brigham Young University Cationic steroidal antimicrobial compounds and methods of manufacturing such compounds
JP2018127399A (ja) * 2015-06-17 2018-08-16 共立製薬株式会社 牛の泌乳期の甚急性又は急性乳房炎に対する治療剤、並びに治療方法
US10226550B2 (en) 2016-03-11 2019-03-12 Brigham Young University Cationic steroidal antimicrobial compositions for the treatment of dermal tissue
US10959433B2 (en) 2017-03-21 2021-03-30 Brigham Young University Use of cationic steroidal antimicrobials for sporicidal activity
CN108553415A (zh) * 2018-06-19 2018-09-21 吉林百年汉克制药有限公司 一种复方甘草酸单铵s注射液药物组合物及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB798655A (en) * 1956-03-15 1958-07-23 Biorex Laboratories Ltd Improvements in or relating to therapeutic compositions
GB799415A (en) * 1956-03-15 1958-08-06 Biorex Laboratories Ltd Improvements in or relating to veterinary compositions
GB843135A (en) * 1957-07-16 1960-08-04 Biorex Laboratories Ltd Glycyrrhetinic acid salts
GB870651A (en) * 1959-03-11 1961-06-14 Biorex Laboratories Ltd Glycyrrhetinic acid derivatives
US4678772A (en) * 1983-02-28 1987-07-07 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions containing glycyrrhizin
JP2599159B2 (ja) * 1987-12-26 1997-04-09 日清製粉株式会社 牛の乳房炎の予防及び治療剤
JPH06305932A (ja) 1993-04-21 1994-11-01 Maruzen Pharmaceut Co Ltd 皮膚外用剤
JPH10226650A (ja) * 1997-02-18 1998-08-25 Ono Pharmaceut Co Ltd グリチルリチン経口投与製剤

Also Published As

Publication number Publication date
EP1208844A1 (de) 2002-05-29
JP3435405B2 (ja) 2003-08-11
CA2363990C (en) 2008-04-01
ES2246282T3 (es) 2006-02-16
DE60113496T2 (de) 2006-07-06
US6872709B2 (en) 2005-03-29
JP2001206849A (ja) 2001-07-31
CA2363990A1 (en) 2002-05-24
EP1208844B1 (de) 2005-09-21
US20040067899A1 (en) 2004-04-08
US20020115622A1 (en) 2002-08-22

Similar Documents

Publication Publication Date Title
DE60113496D1 (de) Verwendung von Glycyrrhizin zur Behandlung von Mastitis.
ATE275145T1 (de) Chinazolinderivate zur behandlung von tumoren
ATE320257T1 (de) (s,s)-reboxetine zur behandlung chronischer schmerzen
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60137631D1 (de) Ireovirus antikörpern zur behandlung von ras-vermittelten, proliferativen erkrankungen
DE60114580D1 (de) Verwendung von cyanochinolinen zur behandlung oder inhibierung von dickdarmpolypen
DE50009504D1 (de) Verwendung von retigabin zur behandlung von neuropathischen schmerzen
DE602004020072D1 (de) 1,2,3,4-tetrasubstituiertes indol zur behandlung von atemwegserkrankungen
DE69934877D1 (de) Biochanin-angereicherter extrakt zur behandlung von estrogenabhängigen erkrankungen
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60136477D1 (de) Retinoide zur behandlung von emphysem
ATE451921T1 (de) Phenylindole zur behandlung von hiv
DE60019158D1 (de) Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien
ATE279386T1 (de) Retinoide zur behandlung von emphysem
DE60130661D1 (de) Verwendung der 13-cis retinsäure zur behandlung von emphysemen
DE50013843D1 (de) Arzneimittel zur behandlung von darmerkrankungen
ATE372118T1 (de) Die verwendung von rosiglitazon zur behandlung von psychiatrischen erkrankungen.
DE50105735D1 (de) Chlorzoxazon zur behandlung von psoriasis
DE60214355D1 (de) Exemestan zur behandlung von hormonabhängigen störungen
DE50114605D1 (de) No-thien-2-yl-essigsaure-derivate und ihre verwendung zur behandlung von migraine bzw. schmerz
ATE273276T1 (de) Cyclobutendion-derivate zur behandlung von artherosclerose
ATE312104T1 (de) Verbindungen zur behandlung von beeinträchtigten fundischen entspannung
DE60016047D1 (de) Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten
DE60021252D1 (de) Antikonvulsiva zur behandlung von autismus

Legal Events

Date Code Title Description
8364 No opposition during term of opposition